Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News The Max Foundation and Novartis deepen global cancer care partnerships with a pledge to reach 100,000 patients annually by 2030 The Max Foundation and Novartis pledge to expand global cancer care, targeting 100,000 patients annually by 2030 with systemic, equity-driven partnerships. bySoujanya RaviSeptember 24, 2025